Array
(
[id] => 2837
[catid] => 75
[title] => 2024 EACTS/EACTAIC/EBCP Guidelines on cardiopulmonary bypass in adult cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => https://www.anes-guide.com/show/2837.html
[link_id] => 0
[tableid] => 0
[inputip] => 106.86.177.165
[inputtime] => 2026-04-14 11:40:54
[updatetime] => 2026-04-14 11:40:54
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://www.ipubmed.cn/Archive/Detail/39955230
[demo_url] =>
[zjpjff] => AHA
[zjfj] =>
[tjqd] =>
[nianfen] => 2025
[guojia] => European Association for Cardio-Thoracic Surgery(E
[pdf] =>
[tjyjyw] =>
[lyyw] => Bivalirudin should be considered as the first-line anticoagulation treatment in patients with acute HIT type 2 who require cardiac surgery.（Ⅱa）
[laiyuan] => 对于需要心脏手术的急性 2 型肝素诱导的血小板减少症患者，应考虑使用比伐卢定作为一线抗凝治疗。（证据等级：高，推荐强度：弱推荐）
[znzldj] => B
[_inputtime] => 1776138054
[_updatetime] => 1776138054
[_nrjc] =>
[_nrsh] =>
)
推荐意见
对于需要心脏手术的急性 2 型肝素诱导的血小板减少症患者，应考虑使用比伐卢定作为一线抗凝治疗。（证据等级：高，推荐强度：弱推荐）
Bivalirudin should be considered as the first-line anticoagulation treatment in patients with acute HIT type 2 who require cardiac surgery.（Ⅱa）
证据评价方法：AHA
指南质量等级：B
年份：2025
国家：European Association for Cardio-Thoracic Surgery(E
Array
(
[id] => 2838
[catid] => 75
[title] => 2024 EACTS/EACTAIC/EBCP Guidelines on cardiopulmonary bypass in adult cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => https://www.anes-guide.com/show/2838.html
[link_id] => 0
[tableid] => 0
[inputip] => 106.86.177.165
[inputtime] => 2026-04-14 11:40:54
[updatetime] => 2026-04-14 11:40:54
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://www.ipubmed.cn/Archive/Detail/39955230
[demo_url] =>
[zjpjff] => AHA
[zjfj] =>
[tjqd] =>
[nianfen] => 2025
[guojia] => European Association for Cardio-Thoracic Surgery(E
[pdf] =>
[tjyjyw] =>
[lyyw] => Anticoagulation with argatroban may be considered in patients with acute HIT type 2 who require cardiac surgery with CPB and have significant renal dysfunction.(Ⅱb）
[laiyuan] => 对于需要体外循环心脏手术且有显著肾功能障碍的急性 2 型肝素诱导的血小板减少症患者，可考虑使用阿加曲班抗凝。（证据等级：中，推荐强度：弱推荐）
[znzldj] => B
[_inputtime] => 1776138054
[_updatetime] => 1776138054
[_nrjc] =>
[_nrsh] =>
)
推荐意见
对于需要体外循环心脏手术且有显著肾功能障碍的急性 2 型肝素诱导的血小板减少症患者，可考虑使用阿加曲班抗凝。（证据等级：中，推荐强度：弱推荐）
Anticoagulation with argatroban may be considered in patients with acute HIT type 2 who require cardiac surgery with CPB and have significant renal dysfunction.(Ⅱb）
证据评价方法：AHA
指南质量等级：B
年份：2025
国家：European Association for Cardio-Thoracic Surgery(E
Array
(
[id] => 2839
[catid] => 71
[title] => 2024 EACTS/EACTAIC/EBCP Guidelines on cardiopulmonary bypass in adult cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => https://www.anes-guide.com/show/2839.html
[link_id] => 0
[tableid] => 0
[inputip] => 106.86.177.165
[inputtime] => 2026-04-14 11:40:54
[updatetime] => 2026-04-14 11:40:54
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://www.ipubmed.cn/Archive/Detail/39955230
[demo_url] =>
[zjpjff] => AHA
[zjfj] =>
[tjqd] =>
[nianfen] => 2025
[guojia] => European Association for Cardio-Thoracic Surgery(E
[pdf] =>
[tjyjyw] =>
[lyyw] => A preoperative assessment of the patient with the surgical-anaesthesiological team is recommended in preparation for CPB.（Ⅰ）
[laiyuan] => 建议在准备体外循环时，与外科-麻醉团队一起对患者进行术前评估。（推荐强度：强推荐）
[znzldj] => B
[_inputtime] => 1776138054
[_updatetime] => 1776138054
[_nrjc] =>
[_nrsh] =>
)
推荐意见
建议在准备体外循环时，与外科-麻醉团队一起对患者进行术前评估。（推荐强度：强推荐）
A preoperative assessment of the patient with the surgical-anaesthesiological team is recommended in preparation for CPB.（Ⅰ）
证据评价方法：AHA
指南质量等级：B
年份：2025
国家：European Association for Cardio-Thoracic Surgery(E
Array
(
[id] => 2840
[catid] => 76
[title] => 2024 EACTS/EACTAIC/EBCP Guidelines on cardiopulmonary bypass in adult cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => https://www.anes-guide.com/show/2840.html
[link_id] => 0
[tableid] => 0
[inputip] => 106.86.177.165
[inputtime] => 2026-04-14 11:40:54
[updatetime] => 2026-04-14 11:40:54
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://www.ipubmed.cn/Archive/Detail/39955230
[demo_url] =>
[zjpjff] => AHA
[zjfj] =>
[tjqd] =>
[nianfen] => 2025
[guojia] => European Association for Cardio-Thoracic Surgery(E
[pdf] =>
[tjyjyw] =>
[lyyw] => It is recommended that the MAP be maintained between 50 and 80 mmHg with vasoconstrictors and vasodilators if required, having ensured that the depth of anaesthesia and pump flow rate are sufficient.（Ⅰ）
[laiyuan] => 建议在确保麻醉深度和泵流量充足后，使用血管收缩剂和血管扩张剂（如需）将平均动脉压维持在 50 至 80 mmHg 之间。（推荐强度：强推荐）
[znzldj] => B
[_inputtime] => 1776138054
[_updatetime] => 1776138054
[_nrjc] =>
[_nrsh] =>
)
推荐意见
建议在确保麻醉深度和泵流量充足后，使用血管收缩剂和血管扩张剂（如需）将平均动脉压维持在 50 至 80 mmHg 之间。（推荐强度：强推荐）
It is recommended that the MAP be maintained between 50 and 80 mmHg with vasoconstrictors and vasodilators if required, having ensured that the depth of anaesthesia and pump flow rate are sufficient.（Ⅰ）
证据评价方法：AHA
指南质量等级：B
年份：2025
国家：European Association for Cardio-Thoracic Surgery(E
Array
(
[id] => 2841
[catid] => 76
[title] => 2024 EACTS/EACTAIC/EBCP Guidelines on cardiopulmonary bypass in adult cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => https://www.anes-guide.com/show/2841.html
[link_id] => 0
[tableid] => 0
[inputip] => 106.86.177.165
[inputtime] => 2026-04-14 11:40:54
[updatetime] => 2026-04-14 11:40:54
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://www.ipubmed.cn/Archive/Detail/39955230
[demo_url] =>
[zjpjff] => AHA
[zjfj] =>
[tjqd] =>
[nianfen] => 2025
[guojia] => European Association for Cardio-Thoracic Surgery(E
[pdf] =>
[tjyjyw] =>
[lyyw] => The use of vasopressors to increase the MAP to values above 80 mmHg during CPB is not recommended.（Ⅲ）
[laiyuan] => 不推荐在体外循环期间使用血管加压药将平均动脉压升高至 80 mmHg 以上.（推荐强度：弱推荐）
[znzldj] => B
[_inputtime] => 1776138054
[_updatetime] => 1776138054
[_nrjc] =>
[_nrsh] =>
)
推荐意见
不推荐在体外循环期间使用血管加压药将平均动脉压升高至 80 mmHg 以上.（推荐强度：弱推荐）
The use of vasopressors to increase the MAP to values above 80 mmHg during CPB is not recommended.（Ⅲ）
证据评价方法：AHA
指南质量等级：B
年份：2025
国家：European Association for Cardio-Thoracic Surgery(E
Array
(
[id] => 2842
[catid] => 76
[title] => 2024 EACTS/EACTAIC/EBCP Guidelines on cardiopulmonary bypass in adult cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => https://www.anes-guide.com/show/2842.html
[link_id] => 0
[tableid] => 0
[inputip] => 106.86.177.165
[inputtime] => 2026-04-14 11:40:54
[updatetime] => 2026-04-14 11:40:54
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://www.ipubmed.cn/Archive/Detail/39955230
[demo_url] =>
[zjpjff] => AHA
[zjfj] =>
[tjqd] =>
[nianfen] => 2025
[guojia] => European Association for Cardio-Thoracic Surgery(E
[pdf] =>
[tjyjyw] =>
[lyyw] => Targeting the MAP during CPB within the limits of individualized cerebral autoregulation data, measured under normocapnic conditions before CPB, should be considered whenever the technical and human skills are available.（Ⅱa）
[laiyuan] => 在技术和人员条件允许时，应考虑在体外循环前在正常二氧化碳条件下测定个体化脑自动调节数据，并将体外循环期间的平均动脉压控制在此数据范围内。（证据等级：高，推荐强度：弱推荐）
[znzldj] => B
[_inputtime] => 1776138054
[_updatetime] => 1776138054
[_nrjc] =>
[_nrsh] =>
)
推荐意见
在技术和人员条件允许时，应考虑在体外循环前在正常二氧化碳条件下测定个体化脑自动调节数据，并将体外循环期间的平均动脉压控制在此数据范围内。（证据等级：高，推荐强度：弱推荐）
Targeting the MAP during CPB within the limits of individualized cerebral autoregulation data, measured under normocapnic conditions before CPB, should be considered whenever the technical and human skills are available.（Ⅱa）
证据评价方法：AHA
指南质量等级：B
年份：2025
国家：European Association for Cardio-Thoracic Surgery(E
Array
(
[id] => 2843
[catid] => 75
[title] => 2024 EACTS/EACTAIC/EBCP Guidelines on cardiopulmonary bypass in adult cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => https://www.anes-guide.com/show/2843.html
[link_id] => 0
[tableid] => 0
[inputip] => 106.86.177.165
[inputtime] => 2026-04-14 11:40:54
[updatetime] => 2026-04-14 11:40:54
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://www.ipubmed.cn/Archive/Detail/39955230
[demo_url] =>
[zjpjff] => AHA
[zjfj] =>
[tjqd] =>
[nianfen] => 2025
[guojia] => European Association for Cardio-Thoracic Surgery(E
[pdf] =>
[tjyjyw] =>
[lyyw] => It is recommended that vasoplegic syndrome during CPB be treated with α1-adrenergic agonists and/or vasopressin.（Ⅰ）
[laiyuan] => 建议使用 α1-肾上腺素能激动剂和/或加压素治疗体外循环期间的血管麻痹综合征。（推荐强度：强推荐）
[znzldj] => B
[_inputtime] => 1776138054
[_updatetime] => 1776138054
[_nrjc] =>
[_nrsh] =>
)
推荐意见
建议使用 α1-肾上腺素能激动剂和/或加压素治疗体外循环期间的血管麻痹综合征。（推荐强度：强推荐）
It is recommended that vasoplegic syndrome during CPB be treated with α1-adrenergic agonists and/or vasopressin.（Ⅰ）
证据评价方法：AHA
指南质量等级：B
年份：2025
国家：European Association for Cardio-Thoracic Surgery(E
Array
(
[id] => 2844
[catid] => 75
[title] => 2024 EACTS/EACTAIC/EBCP Guidelines on cardiopulmonary bypass in adult cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => https://www.anes-guide.com/show/2844.html
[link_id] => 0
[tableid] => 0
[inputip] => 106.86.177.165
[inputtime] => 2026-04-14 11:40:54
[updatetime] => 2026-04-14 11:40:54
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://www.ipubmed.cn/Archive/Detail/39955230
[demo_url] =>
[zjpjff] => AHA
[zjfj] =>
[tjqd] =>
[nianfen] => 2025
[guojia] => European Association for Cardio-Thoracic Surgery(E
[pdf] =>
[tjyjyw] =>
[lyyw] => In refractory vasoplegic syndrome, alternative drugs (methylene blue or terlipressin) should be considered, alone or in combination.（Ⅱa）
[laiyuan] => 对于难治性血管麻痹综合征，应考虑单独或联合使用替代药物（亚甲蓝或特利加压素）。（证据等级：高，推荐强度：弱推荐）
[znzldj] => B
[_inputtime] => 1776138054
[_updatetime] => 1776138054
[_nrjc] =>
[_nrsh] =>
)
推荐意见
对于难治性血管麻痹综合征，应考虑单独或联合使用替代药物（亚甲蓝或特利加压素）。（证据等级：高，推荐强度：弱推荐）
In refractory vasoplegic syndrome, alternative drugs (methylene blue or terlipressin) should be considered, alone or in combination.（Ⅱa）
证据评价方法：AHA
指南质量等级：B
年份：2025
国家：European Association for Cardio-Thoracic Surgery(E
Array
(
[id] => 2845
[catid] => 75
[title] => 2024 EACTS/EACTAIC/EBCP Guidelines on cardiopulmonary bypass in adult cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => https://www.anes-guide.com/show/2845.html
[link_id] => 0
[tableid] => 0
[inputip] => 106.86.177.165
[inputtime] => 2026-04-14 11:40:54
[updatetime] => 2026-04-14 11:40:54
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://www.ipubmed.cn/Archive/Detail/39955230
[demo_url] =>
[zjpjff] => AHA
[zjfj] =>
[tjqd] =>
[nianfen] => 2025
[guojia] => European Association for Cardio-Thoracic Surgery(E
[pdf] =>
[tjyjyw] =>
[lyyw] => Hydroxocobalamin or angiotensin II may be considered to treat vasoplegic syndrome during CPB.(Ⅱb）
[laiyuan] => 可考虑使用羟钴胺或血管紧张素 II 治疗体外循环期间的血管麻痹综合征。（证据等级：中，推荐强度：弱推荐）
[znzldj] => B
[_inputtime] => 1776138054
[_updatetime] => 1776138054
[_nrjc] =>
[_nrsh] =>
)
推荐意见
可考虑使用羟钴胺或血管紧张素 II 治疗体外循环期间的血管麻痹综合征。（证据等级：中，推荐强度：弱推荐）
Hydroxocobalamin or angiotensin II may be considered to treat vasoplegic syndrome during CPB.(Ⅱb）
证据评价方法：AHA
指南质量等级：B
年份：2025
国家：European Association for Cardio-Thoracic Surgery(E
Array
(
[id] => 2846
[catid] => 80
[title] => 2026 American Society of Anesthesiologists Practice Guideline on Perioperative Pain Management Using Local and Regional Analgesia for Cardiothoracic Surgeries, Mastectomy, and Abdominal Surgeries
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => https://www.anes-guide.com/show/2846.html
[link_id] => 0
[tableid] => 0
[inputip] => 106.86.177.165
[inputtime] => 2026-04-14 11:40:54
[updatetime] => 2026-04-14 11:40:54
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://www.ipubmed.cn/Archive/Detail/41363869
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2026
[guojia] => American Society of Anesthesiologists (ASA)
[pdf] =>
[tjyjyw] =>
[lyyw] => For adults undergoing open cardiothoracic surgeries including lobectomy, aortic valve replacement, coronary artery bypass grafts, mitral valve repair, or septal repair, we recommend fascial plane blocks to reduce pain and/or opioid requirements in the first 24 h postoperatively.
[laiyuan] => 对于接受开放性心胸外科手术（包括肺叶切除术、主动脉瓣置换术、冠状动脉旁路移植术、二尖瓣修复术或间隔修复术）的成人患者，推荐使用筋膜平面阻滞以减少术后24小时内的疼痛和/或阿片类药物需求（证据等级：高，推荐强度：强推荐）
[znzldj] => B
[_inputtime] => 1776138054
[_updatetime] => 1776138054
[_nrjc] =>
[_nrsh] =>
)
推荐意见
对于接受开放性心胸外科手术（包括肺叶切除术、主动脉瓣置换术、冠状动脉旁路移植术、二尖瓣修复术或间隔修复术）的成人患者，推荐使用筋膜平面阻滞以减少术后24小时内的疼痛和/或阿片类药物需求（证据等级：高，推荐强度：强推荐）
For adults undergoing open cardiothoracic surgeries including lobectomy, aortic valve replacement, coronary artery bypass grafts, mitral valve repair, or septal repair, we recommend fascial plane blocks to reduce pain and/or opioid requirements in the first 24 h postoperatively.
证据评价方法：GRADE
指南质量等级：B
年份：2026
国家：American Society of Anesthesiologists (ASA)
